drugset / Trial / NCT02509481

Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study

NCT02509481

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine whether repeated ivermectin mass drug administrations to Burkinabé villagers, performed in three week intervals over the rainy-season, is well-tolerated and safe, and also effective in reducing local malaria transmission and thus clinical malaria episodes in treated village children.

Timeline

Start
2015-06
Primary completion
2015-11
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ivermectin Small molecule 150 ug/kg Oral
Background Albendazole Small molecule 400 mg Oral

Indications